Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

NCT05095376 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

265

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma

Interventions

DRUG: Lomustine
PROCEDURE: Magnetic Resonance Imaging
RADIATION: Photon Beam Radiation Therapy
OTHER: Questionnaire Administration
DRUG: Temozolomide

Sponsor

NRG Oncology

Collaborators

[object Object]